Skip to main content
Top
Published in: Malaria Journal 1/2021

Open Access 01-12-2021 | Malaria | Research

Knowledge, attitudes and practices (KAP) to assess the impact of school children's awareness of malaria using the MOSKI KIT® tool: study case of some Dakar schools in Senegal

Authors: Isaac Akhénaton Manga, Aïssatou Gaye, Aliou Dia, Ekoue Kouevidjin, Maria Rosa Dos Reis, Aboubakry Sadikh Niang, Amy Ndao Fall, Christelle Maitre Anquetil, Jean Louis Abdourahim Ndiaye

Published in: Malaria Journal | Issue 1/2021

Login to get access

Abstract

Background

MOSKI KIT® is a fun tool designed to interest children for prevention and management of malaria. This study was carried out with the objective to assess the short- and long-term impacts of this tool on the knowledge, attitudes, and practices of school children, and on the transmission of the knowledge received at the household level as well.

Method

The study took place in elementary schools in the city centre (with relatively low endemicity) and in the Niayes area (at high risk of anopheline and malaria) in the Dakar region of Senegal. The various schools chosen for this study were divided into an intervention group and a control group. The intervention schools were also divided into two subgroups, a full package subgroup and another partial package. During this study three surveys were conducted, the first one before exposure to the MOSKI KIT®, the second one a week later and the third a year later. For the control schools only one survey was conducted and at the same time than the third for the intervention schools. Two household surveys (a week and a year after exposure) were also conducted for the intervention schools against one for the control schools.

Results

Before sensitization, the proportion of school children with a grade above or equal to the average was 50% for the complete package subgroup (CPS) and 53% for the partial package subgroup (PPS). A week later, these proportions were 69% and 71%, respectively for the complete and PPSs. A year later, they were 99.4% for the CPS, 98.1% for the PPS and 99.5% for the control group; The number of children who spoke to their parents about malaria was greater in intervention schools than that of control schools. They were 46.63% and 32.58%, respectively in intervention and control schools.

Conclusion

The MOSKI KIT, has enabled an increase of the knowledge of school children about malaria in the short term and favoured its retention in the long term. However, its impact was not felt on their attitudes and practices.
Literature
1.
go back to reference WHO. World malaria report. Geneva: World Health Organization; 2018. WHO. World malaria report. Geneva: World Health Organization; 2018.
2.
go back to reference Kalnins IV, Hart C, Ballantyne P, Quartaro G, Love R, Sturis G, et al. School-based community development as a health promotion strategy for children. Health Promot Int. 1994;9:269–79.CrossRef Kalnins IV, Hart C, Ballantyne P, Quartaro G, Love R, Sturis G, et al. School-based community development as a health promotion strategy for children. Health Promot Int. 1994;9:269–79.CrossRef
4.
go back to reference African Union Malaria Progress Report 2018. Accessed 12 July 2019. African Union Malaria Progress Report 2018. Accessed 12 July 2019.
5.
go back to reference Sauvé L, Renaud L, Gauvin M. Une analyse des écrits sur les impacts du jeu sur l’apprentissage. Revue Sciences Education. 2007;33:1. Sauvé L, Renaud L, Gauvin M. Une analyse des écrits sur les impacts du jeu sur l’apprentissage. Revue Sciences Education. 2007;33:1.
6.
go back to reference Bhati PG, Kant R, Srivastava HC, Malaviya VS, Pujara PK. Role of health education in school-children with particular reference to malaria. Indian J Malariol. 1995;32:93–8.PubMed Bhati PG, Kant R, Srivastava HC, Malaviya VS, Pujara PK. Role of health education in school-children with particular reference to malaria. Indian J Malariol. 1995;32:93–8.PubMed
7.
go back to reference Programme National de Lutte contre le Paludisme. Enquête Nationale sur les Indicateurs du Paludisme au Sénégal, Rapport Final. Dakar, 2017 Programme National de Lutte contre le Paludisme. Enquête Nationale sur les Indicateurs du Paludisme au Sénégal, Rapport Final. Dakar, 2017
8.
go back to reference Onyango-Ouma W, Aagaard-Hansen J, Jensen BB. The potential of school children as health change agents in rural western Kenya. Soc Sci Med. 2005;61:1711–22.CrossRef Onyango-Ouma W, Aagaard-Hansen J, Jensen BB. The potential of school children as health change agents in rural western Kenya. Soc Sci Med. 2005;61:1711–22.CrossRef
9.
go back to reference Ogutu RO, Oloo AJ, Ekissa WS, Genga IO, Mulaya N, Githure JI. The effect of participatory school health programme on the control of malaria. East Afr Med J. 1992;69:298–302.PubMed Ogutu RO, Oloo AJ, Ekissa WS, Genga IO, Mulaya N, Githure JI. The effect of participatory school health programme on the control of malaria. East Afr Med J. 1992;69:298–302.PubMed
10.
go back to reference Slate Afrique. RDC: Une bande dessinée pour lutter contre le paludisme à l’école. www.slateafrique.com › rdc-une-bande-dessinée-pour-lutter-contre-le-paludisme. 2013. Slate Afrique. RDC: Une bande dessinée pour lutter contre le paludisme à l’école. www.​slateafrique.​com › rdc-une-bande-dessinée-pour-lutter-contre-le-paludisme. 2013.
11.
go back to reference Nankabirwa J, Cundill B, Clarke S, Kabatereine N, Rosenthal PJ, Dorsey G, et al. Efficacy, safety, and tolerability of three regimens for prevention of malaria: a randomized, placebo-controlled trial in Ugandan school children. PLoS ONE. 2010;5:e13438.CrossRef Nankabirwa J, Cundill B, Clarke S, Kabatereine N, Rosenthal PJ, Dorsey G, et al. Efficacy, safety, and tolerability of three regimens for prevention of malaria: a randomized, placebo-controlled trial in Ugandan school children. PLoS ONE. 2010;5:e13438.CrossRef
12.
go back to reference Nankabirwa JI, Wandera B, Amuge P, Kiwanuka N, Dorsey G, Rosenthal PJ, et al. Impact of intermittent preventive treatment with dihydroartemisinin-piperaquine on malaria in Ugandan school children: a randomized, placebo-controlled trial. Clin Infect Dis. 2014;58:1404–12.CrossRef Nankabirwa JI, Wandera B, Amuge P, Kiwanuka N, Dorsey G, Rosenthal PJ, et al. Impact of intermittent preventive treatment with dihydroartemisinin-piperaquine on malaria in Ugandan school children: a randomized, placebo-controlled trial. Clin Infect Dis. 2014;58:1404–12.CrossRef
13.
go back to reference Ndiaye JL, Cissé B, Ba EH, Gomis JF, Ndour CT, Molez F, et al. Safety of seasonal malaria chemoprevention (SMC) with sulfadoxine-pyrimethamine plus amodiaquine when delivered to children under 10 years of age by district health Services in Senegal results from a stepped-Wedge cluster randomized trial. PLoS ONE. 2016;11:e0162563.CrossRef Ndiaye JL, Cissé B, Ba EH, Gomis JF, Ndour CT, Molez F, et al. Safety of seasonal malaria chemoprevention (SMC) with sulfadoxine-pyrimethamine plus amodiaquine when delivered to children under 10 years of age by district health Services in Senegal results from a stepped-Wedge cluster randomized trial. PLoS ONE. 2016;11:e0162563.CrossRef
Metadata
Title
Knowledge, attitudes and practices (KAP) to assess the impact of school children's awareness of malaria using the MOSKI KIT® tool: study case of some Dakar schools in Senegal
Authors
Isaac Akhénaton Manga
Aïssatou Gaye
Aliou Dia
Ekoue Kouevidjin
Maria Rosa Dos Reis
Aboubakry Sadikh Niang
Amy Ndao Fall
Christelle Maitre Anquetil
Jean Louis Abdourahim Ndiaye
Publication date
01-12-2021
Publisher
BioMed Central
Keyword
Malaria
Published in
Malaria Journal / Issue 1/2021
Electronic ISSN: 1475-2875
DOI
https://doi.org/10.1186/s12936-021-03829-5

Other articles of this Issue 1/2021

Malaria Journal 1/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.